Literature DB >> 3149718

Platelet-activating factor-induced contraction of guinea-pig lung parenchymal strips: possible involvement of arachidonate metabolites.

M Del Monte1, A Subissi.   

Abstract

The identification of the mediators possibly involved in platelet-activating factor (PAF)-induced contraction of guinea-pig lung parenchymal strips (GPLP) was attempted by means of antagonists and inhibitors. Histamine, serotonin, acetylcholine (ACh) or other transmitters released from the nerve terminals are not likely to play a role in this response, since specific antagonists and tetrodotoxin did not affect the contraction. PAF antagonists (brotizolam and WEB 2086) produced a concentration-dependent inhibition of the contraction. Inhibitors of TXA2 synthesis (dazoxiben) and of 5-lipoxygenase (nordihydroguaiaretic acid and AA 861) and antagonists of TXA2 (ICI 159995) and peptidoleukotrienes (L 649923 and LY 171883, but not FPL 55712) produced a significant inhibition of the PAF-induced response at concentrations which did not reduce the ACh-induced response. These results suggest that arachidonate metabolites, both of the cyclo-oxygenase and of the lipoxygenase pathway, are determinants of the PAF-induced contraction of GPLP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3149718     DOI: 10.1007/bf00172120

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

Review 1.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

2.  Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.

Authors:  N P Stimler; J T O'Flaherty
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

3.  Anaphylactic actions of platelet-activating factor.

Authors:  N P Stimler; C M Bloor; T E Hugli; R L Wykle; C E McCall; J T O'Flaherty
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

4.  Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

Authors:  B B Vargaftig; J Lefort; M Chignard; J Benveniste
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

5.  L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist.

Authors:  T R Jones; R Young; E Champion; L Charette; D Denis; A W Ford-Hutchinson; R Frenette; J Y Gauthier; Y Guindon; M Kakushima
Journal:  Can J Physiol Pharmacol       Date:  1986-08       Impact factor: 2.273

6.  Characterization of platelet activating factor (PAF)-acether-induced contractions of guinea-pig lung strips by selected inhibitors of arachidonic acid metabolism and by PAF-acether antagonists.

Authors:  C Touvay; B Vilain; A Etienne; P Sirois; P Borgeat; P Braquet
Journal:  Immunopharmacology       Date:  1986-10

7.  The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.

Authors:  J Lefort; D Rotilio; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1984-07       Impact factor: 8.739

8.  LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.

Authors:  J H Fleisch; L E Rinkema; K D Haisch; D Swanson-Bean; T Goodson; P P Ho; W S Marshall
Journal:  J Pharmacol Exp Ther       Date:  1985-04       Impact factor: 4.030

9.  Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig.

Authors:  I Maridonneau-Parini; V Lagente; J Lefort; J Randon; F Russo-Marie; B B Vargaftig
Journal:  Biochem Biophys Res Commun       Date:  1985-08-30       Impact factor: 3.575

10.  Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro.

Authors:  J M Drazen; K F Austen; R A Lewis; D A Clark; G Goto; A Marfat; E J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.